Skip to main content

Articles By Janet Pope, MD, MPH, FRCPC

Telemedicine.MD.Computer.phone (keep)

How are RA patients doing using telemedicine/virtual care?

By Janet Pope, MD, MPH, FRCPC
02 December 2020

Rheumatologists switched their practices overnight from primarily in person to nearly all virtual care as COVID-19 pandemic geared up in March 2020 and then to a blend of in person and virtual care. How are RA patients doing?

Read Article
Lknee.OA_.jpg

What’s new in knee osteoarthritis that matters?

By Janet Pope, MD, MPH, FRCPC
23 November 2020

Are intra-articular steroid injections effective in symptomatic knee OA? Do they accelerate cartilage loss? Does weight less actually help? Do we have DMARDs for knee OA? Insights from 2020 ACR Convergence.

Read Article
chain-2364830_640.jpg

Link Between Obstructive Lung Disease and Developing RA?

By Janet Pope, MD, MPH, FRCPC
09 December 2019

We all know that the microbiome in the gut may be very important for multiple immune diseases. However, new findings from the ACR, 2019 in Atlanta reinforce how important the interface is between the lungs and developing rheumatoid arthritis.

Read Article
Screen%20Shot%202019-06-12%20at%204.26.31%20PM.png

Be ‘on point’: Guidelines for rheumatic complications of immunotherapy

By Janet Pope, MD, MPH, FRCPC
05 July 2019

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. At EULAR 2019, Madrid, several recommendations including RA, SLE, and Sjogren’s syndrome have been developed. Agreement for principles with respect to the treatment of immune mediated adverse events from cancer immunotherapy are lacking.

Read Article
eye%20exa.jpg (keep)

Blinded by the Use of Antimalarials in Lupus?

By Janet Pope, MD, MPH, FRCPC
01 July 2019

Editor's note: July 1 - 5, RheumNow is running the best of EULAR 2019 meeting. Hydroxychloroquine (HCQ) will decrease SLE flares improve lipids, decrease clots, improve survival, augment the response to mycophenolate and are the cornerstone of treatment as per the SLE EULAR gui

Read Article
eye%20exa.jpg (keep)

Blinded by the Use of Antimalarials in Lupus?

By Janet Pope, MD, MPH, FRCPC
17 June 2019

Hydroxychloroquine (HCQ) will decrease SLE flares improve lipids, decrease clots, improve survival, augment the response to mycophenolate and are the cornerstone of treatment as per the SLE EULAR guidelines presented at EULAR 2019 in Madrid and also published in ARD.

Read Article
blood%20test.jpg

Could Measuring Drug Levels with TNF Treatment Hurt Your Patients?

By Janet Pope, MD, MPH, FRCPC
17 June 2018

Our colleagues in gastroenterology measure drug levels with certain biologics used in inflammatory bowel disease in order to increase the dose for optimal benefit if the patient has a low trough level (i.e. targeting drug level).

Read Article
T2T.RA_.jpg

We Measure What we do in RA, But so What?

By Janet Pope, MD, MPH, FRCPC
17 June 2018

We are supposed to treat to a target (T2T) in RA. In other words, measure many components of the disease and its activity and calculate a score and if the patient is not in remission (or a low state if remission is not achievable) we are to make a treatment change.

Read Article
death%20rates.%20JAMA.png

Does RA kill you? Let me count the ways….and what you can do about it

By Janet Pope, MD, MPH, FRCPC
17 June 2018

There were many presentations at EULAR 2018 in Amsterdam about the mortality of RA.

Read Article
×